The compounding pharmacies market from the non-sterile segment is expected to achieve over 5.5% CAGR during 2020 to 2026. Rising demand for non-sterile medications such as syrups, capsules and pills will foster the segment growth.

SottoPelle® named top Hormone Therapy Clinic for Second Consecutive Year in Arizona by Ranking Arizona®

Tune in to Fox Business Network as sponsored programming and Bloomberg International on August 13, 2016. See market-by-market listings below.

Harbor Compounding Pharmacy proudly presents The Second CME sponsored seminar event entitled, The Power of Rhythmic Hormone Replacement, October 24th in Las Vegas Nevada. Hosted by Dr. Julie Taguchi and Dr. Brett Jacques, the seminar covers a full range of topics in rhythmic hormone replacement therapy aimed at educating healthcare practitioners.

Harbor Compounding Pharmacy is proud to announce that they have been renewed for their accreditation by the Pharmacy Compounding Accreditation Board (PCAB) for meeting and/or exceeding national quality standards for sterile and non-sterile pharmacy compounding. PCAB is a service of the Accreditation Commission for Health Care (ACHC).

A recent scientific study confirms positive findings on a medical treatment method featuring a new combination of drugs and a new delivery system. It significantly improves the quality of life for breast cancer survivors.